Purpose
South Coast Peptides publishes scientific and analytical information to help qualified laboratories and business-to-business research customers understand material identity, analytical documentation, published research context, and procurement considerations. Website content is not medical advice and does not provide personal-use, dosing, administration, diagnostic, or treatment guidance.
Source standards
Scientific content should prioritize primary peer-reviewed literature, PubMed-indexed research, recognized scientific journals, ClinicalTrials.gov, FDA and other governmental sources, and established scientific databases. Secondary sources may be used for context but should not replace primary evidence when primary evidence is reasonably available.
Evidence distinctions
We distinguish in-vitro or mechanistic evidence, animal or preclinical evidence, human clinical evidence, and regulatory or development status. Findings from one evidence level are not presented as though they establish another. Evidence for an individual molecule is not automatically attributed to a blend, fragment, analogue, salt form, or commercially named material unless the identity is supported.
Material identity
Product names can be ambiguous. Where sequence, salt form, conjugation, counterion, formulation, or commercial naming creates uncertainty, the lot-specific identity and analytical record take precedence over shorthand marketing terminology.
Analytical claims
Purity statements are method- and lot-dependent. A chromatographic purity result does not, by itself, establish molecular identity, exact content, sterility, endotoxin status, absence of every impurity, pharmaceutical quality, or suitability for any particular research protocol.
Review and updates
Research resources display publication and modification dates where appropriate. Content may be updated when new peer-reviewed evidence, regulatory developments, analytical information, or corrections materially change the accuracy or usefulness of a page.
Corrections
If a material factual error is identified, South Coast Peptides may correct the affected content and update the modification date. Requests for scientific corrections may be submitted through the Contact page with the page URL, the disputed statement, and supporting source material.
Commercial independence
The fact that South Coast Peptides supplies a research material does not alter the evidence standard used to describe that material. Scientific summaries should identify uncertainty and limitations even when doing so is commercially inconvenient.
Research-use boundary
Scientific literature is discussed for educational and research context only. Publication of human clinical research does not mean that a material sold by South Coast Peptides is a finished pharmaceutical product, approved drug, compounded preparation, or material intended for human or veterinary administration.